MedPath

Vancomycin Reduction Practices (VRP) in the NICU

Not Applicable
Not yet recruiting
Conditions
Antibiotic Stewardship
Neonatal Sepsis, Late-Onset
Vancomycin
Registration Number
NCT06772675
Lead Sponsor
Children's Hospital of Philadelphia
Brief Summary

This multi-center, cluster randomized study aimed at improving implementation of vancomycin reducing practices (VRP) in NICUs. Sites will be recruited and randomized to receive either external facilitation or no external facilitation to assess the effect on center-level fidelity to the core components of VRP implementation. Interventions available to both study arms are directed at hospital staff and includes identification of local champions, educational outreach, unit-level audit \& feedback, and use of a clinical decision support tool.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
13
Inclusion Criteria
  • Level III NICU
  • Affiliated with Kaiser Permanente Northern California (KPNC) or Children's Hospital of Philadelphia Newborn Care Network (CNBCN)
  • Recruited by study team
Exclusion Criteria
  • Site not recruited for the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Fidelity of VRP use2.5 years - From beginning of implementation phase to the end of the sustainment phase

Proportion of LOS evaluations performed with high fidelity. High fidelity is defined when the evaluation follows all three core components of VRP use.

Secondary Outcome Measures
NameTimeMethod
Appropriateness/acceptability2.5 years - From beginning of implementation phase to the end of the sustainment phase

Response to questions about whether VRP was agreeable and/or a good fit fot the unit measured using validated instruments comprising of 4-point Likert scales. (Weiner et al)

© Copyright 2025. All Rights Reserved by MedPath